These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8256106)

  • 1. Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
    Rombo L; Angel VH; Friman G; Hellgren U; Mittelholzer ML; Stürchler D
    Trop Med Parasitol; 1993 Sep; 44(3):254-6. PubMed ID: 8256106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
    Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
    Salako LA; Adio RA; Walker O; Sowunmi A; Stürchler D; Mittelholzer ML; Reber-Liske R; Dickschat U
    Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis.
    Hellgren U; Angel VH; Bergqvist Y; Arvidsson A; Forero-Gomez JS; Rombo L
    Trans R Soc Trop Med Hyg; 1990; 84(1):46-9. PubMed ID: 2345926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
    Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
    Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
    Reisinger EC; Horstmann RD; Dietrich M
    Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
    Thimasarn K; Pinichpongse S; Malikul S; Rooney W; Tansophalaks S
    Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):404-11. PubMed ID: 2075482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
    Stemberger H; Leimer R; Wiedermann G
    Acta Trop; 1984 Dec; 41(4):391-9. PubMed ID: 6152120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.
    Marquart L; Baker M; O'Rourke P; McCarthy JS
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4249-59. PubMed ID: 25963983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects.
    Sarikabhuti B; Keschamrus N; Noeypatimanond S; Weidekamm E; Leimer R; Wernsdorfer W; Kölle EU
    Acta Trop; 1988 Sep; 45(3):217-24. PubMed ID: 2903623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
    Na Bangchang K; Karbwang J; Banmairuroi V; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):221-5. PubMed ID: 8266221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mefloquine--its 20 years in the Thai Malaria Control Program.
    Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical efficacy of and tolerance for lariam (mefloquine) in tropical malaria in the south of the Socialist Republic of Vietnam].
    Shcherbakov AM; Nguyen TL; Chin KA; Chan KT; Rabinovich SA; Nguyen VD; Chan VF; Nguyen TL; Vu TT; Padelt H
    Med Parazitol (Mosk); 1990; (5):57-9. PubMed ID: 2266908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.